Dashboard
Manage Tickers

ARWR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
11/19/2025 17:35:20

rbc-capital-maintains-outperform-on-arrowhead-pharma-raises-price-target-to-52
RBC Capital Maintains Outperform on Arrowh...
11/19/2025 15:58:37

RBC Capital analyst Luca Issi maintains Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and raises the price target from $4...

chardan-capital-maintains-buy-on-arrowhead-pharma-maintains-60-price-target
Chardan Capital Maintains Buy on Arrowhead...
11/19/2025 13:22:15

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $60 price target.

piper-sandler-maintains-overweight-on-arrowhead-pharma-raises-price-target-to-70
Piper Sandler Maintains Overweight on Arro...
11/19/2025 12:12:29

Piper Sandler analyst Edward Tenthoff maintains Arrowhead Pharma (NASDAQ:ARWR) with a Overweight and raises the price target...

fda-clears-arrowhead-pharmas-first-ever-home-injection-for-rare-fat-disorder
FDA Clears Arrowhead Pharma's First-Ever H...
11/18/2025 18:07:28

Arrowhead Pharmaceuticals won FDA approval for Redemplo (plozasiran), an siRNA drug reducing high triglycerides in adults with ...

trading-halt-halt-status-updated-at-121000-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 12:10...
11/18/2025 17:10:04

arrowhead-pharmaceuticals-receives-fda-approval-of-redemplo-to-reduce-triglycerides-in-adults-with-familial-chylomicronemia-syndrome
Arrowhead Pharmaceuticals Receives FDA App...
11/18/2025 16:13:18

https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025

trading-halt-halted-at-110646-am-et---trading-halt-halt-news-pending
Trading Halt: Halted at 11:06:46 a.m. ET -...
11/18/2025 16:06:50

morgan-stanley-maintains-equal-weight-on-arrowhead-pharma-raises-price-target-to-45
Morgan Stanley Maintains Equal-Weight on A...
11/12/2025 17:12:48

Morgan Stanley analyst Michael Ulz maintains Arrowhead Pharma (NASDAQ:ARWR) with a Equal-Weight and raises the price target ...

crispr-therapeutics-investigational-gene-therapy-shows-promising-lipid-lowering-effects-in-early-trial
CRISPR Therapeutics' Investigational Gene ...
11/11/2025 14:50:51

CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its...

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
10/08/2025 10:20:12

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

arrowhead-pharmaceuticals-files-to-begin-phase-12a-trial-for-dual-target-rnai-drug-aro-dimer-pa-aims-to-treat-atherosclerotic-cardiovascular-disease-from-mixed-hyperlipidemia
Arrowhead Pharmaceuticals Files To Begin P...
10/07/2025 11:34:04

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has filed a request for regulatory clearance to initiate ...

4-biotechnology-stocks-that-outshine-in-momentum-amid-strong-technicals
4 Biotechnology Stocks That Outshine In Mo...
09/29/2025 11:11:04

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week ...

arrowhead-sues-ionis-seeking-declaratory-judgment-on-patent-validity-over-plozasiran-commercialization
Arrowhead Sues Ionis Seeking Declaratory J...
09/11/2025 11:31:48

arrowhead-pharma-files-request-for-regulatory-clearance-to-initiate-phase-12a-clinical-trial-of-aro-mapt-investigational-rnai-therapeutic-for-tauopathies
Arrowhead Pharma Files Request For Regulat...
09/10/2025 11:31:54

 - In preclinical studies presented today at the RNA Leaders USA Congress 2025, investigational ARO-MAPT demonstrated potent an...

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
09/02/2025 16:05:27

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Core News & Articles
Arrowhead Pharmaceuticals Inks Global Lice...
09/02/2025 11:32:42

Upon closing, Arrowhead will receive an upfront payment of $200 millionNovartis will receive an exclusive worldwide license to ...

Core News & Articles
Arrowhead Receives $100M Milestone From Sa...
08/13/2025 20:30:04

- Arrowhead has elected to receive approximately $50 million worth of Arrowhead common stock from Sarepta, which will be placed...

chardan-capital-maintains-buy-on-arrowhead-pharma-maintains-60-price-target
Chardan Capital Maintains Buy on Arrowhead...
08/11/2025 11:42:35

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $60 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION